---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-029849"
form_type: "8-K"
ticker: "XTNT"
cik: "0001453593"
company_name: "Xtant Medical Holdings, Inc."
filed_at: "2022-10-28T23:59:59+00:00"
generated_at: "2026-06-22T22:32:35.446423+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Xtant stockholders approve 8.5M share increase in 2018 Equity Incentive Plan

## Summary
- Stockholders approved Second Amended and Restated 2018 Equity Incentive Plan on October 26, 2022.
- Amendment increases shares available for issuance by 8,500,000 to a total capped by plan terms.
- Other plan provisions unchanged; plan expires July 31, 2028 unless earlier terminated.
- All six director nominees elected with >81.7M votes each; auditor ratified; say-on-pay approved.
- Plan vote: 82,054,439 for, 809,383 against, 3,618 abstentions, 2,002,504 broker non-votes.

## SEC filing metadata
- accession: 0001493152-22-029849
- form_type: 8-K
- ticker: XTNT
- cik: 0001453593
- company_name: Xtant Medical Holdings, Inc.
- filed_at: 2022-10-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1453593/000149315222029849/0001493152-22-029849-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1453593/000149315222029849/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-029849
- JSON: https://secwatch.observer/filing/0001493152-22-029849.json
- Plain text: https://secwatch.observer/filing/0001493152-22-029849.txt

## Key facts
- Shareholder Votes
  Xtant Medical Holdings, Inc. shareholders approved Ratification of appointment of independent registered public accounting firm at the 2022-10-26 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2022-10-26
  source text: Proposal No. 2 - The ratification of the appointment of Plante & Moran, PLLC as the Company’s independent registered public accounting firm for the year ending December 31, 2022 was approved by the following final voting results: Votes For Votes Against Votes Abstained Broker Non-Votes 84,845,095 12,191 12,658 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1453593/000149315222029849/0001493152-22-029849-index.htm
- Shareholder Votes
  Xtant Medical Holdings, Inc. shareholders approved Approval of Second Amended and Restated 2018 Equity Incentive Plan at the 2022-10-26 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2022-10-26
  source text: Proposal No. 4 - The Xtant Medical Holdings, Inc. Second Amended and Restated 2018 Equity Incentive Plan was approved by the following final voting results: Votes For Votes Against Votes Abstained Broker Non-Votes 82,054,439 809,383 3,618 2,002,504
  evidence_url: https://www.sec.gov/Archives/edgar/data/1453593/000149315222029849/0001493152-22-029849-index.htm
- Shareholder Votes
  Xtant Medical Holdings, Inc. shareholders approved Election of six director nominees at the 2022-10-26 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2022-10-26
  source text: Proposal No. 1 - The six director nominees proposed by the Board were elected to serve as members of the Board until the next annual meeting of stockholders and until their respective successors have been duly elected and qualified by the following final voting results: Votes For Votes Withheld Broker Non-Votes John Bakewell 82,400,159 467,281 2,002,504 Sean E. Browne 81,806,196 1,061,244 2,002,504 Michael Eggenberg 81,755,204 1,112,236 2,002,504 Robert McNamara 82,387,100 480,340 2,002,504 Matthew Rizzo 81,755,616 1,111,824 2,002,504 Stavros Vizirgianakis 81,782,213 1,085,227 2,002,504
  evidence_url: https://www.sec.gov/Archives/edgar/data/1453593/000149315222029849/0001493152-22-029849-index.htm
- Shareholder Votes
  Xtant Medical Holdings, Inc. shareholders approved Advisory vote on executive compensation at the 2022-10-26 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2022-10-26
  source text: Proposal No. 3 - The compensation of the Company’s executive officers named in the proxy statement was approved, on an advisory basis, by the following final voting results: Votes For Votes Against Votes Abstained Broker Non-Votes 82,804,076 56,671 6,693 2,002,504
  evidence_url: https://www.sec.gov/Archives/edgar/data/1453593/000149315222029849/0001493152-22-029849-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.